Hetero Labs Limited Posaconazole Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Posaconazole Export Records India — #2 Exporter, 30 Shipments, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Posaconazole

India Pharmaceutical Trade Intelligence

$115.1M51 Suppliers41 CountriesHS 30049099

ExportsIndia → UNITED STATES79.5%India → CYPRUS8.5%

ImportsBELGIUM → India$367.8K UNITED STATES → India$254.9K

#1 Supplier: AET LABORATORIES

Hetero Labs Limited — Posaconazole Exporter #2 | $1.5M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Posaconazole Exporter Profile

Indian Pharmaceutical Exporter · #2 for Posaconazole · $1.5M export value · DGFT Verified

Hetero Labs Limited is the #2 Indian exporter of Posaconazole with $1.5M in export value and 30 verified shipments. Hetero Labs Limited holds a 10.9% market share in Posaconazole exports across 6 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Posaconazole Export Profile: Buyers & Destinations

Hetero Labs Limited Posaconazole export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Posaconazole?

Country	Value	Shipments	Share
UNITED STATES	$900.0K	18	72.3%
UNITED KINGDOM	$150.0K	3	12.0%
NETHERLANDS	$123.1K	4	9.9%
SPAIN	$61.0K	2

Who Are the Top Buyers of Posaconazole from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF....	UNITED STATES	$300.0K	6
TO THE ORDER OF	UNITED STATES	$210.6K	5
CAMBER PHARMACEUTICALS INC	UNITED STATES	$150.0K	3
TO THE ORDER OF	NETHERLANDS	$123.1K	4
M S TO THE ORDER OF NORTHSTAR DISTRIBUTION CENTER	UNITED STATES	$100.0K	2
CAMBER PHARMACEUTICALS INC.	UNITED STATES	$100.0K	2
TO THE ORDER OF :	UNITED STATES	$50.0K	1
TO THE ORDER	UNITED STATES	$50.0K	1
TARBIS FARMA, S.L.	SPAIN	$50.0K	1
TO THE ORDER OF;	UNITED KINGDOM	$50.0K	1

Hetero Labs Limited supplies Posaconazole to 13 buyers globally. The largest buyer is TO THE ORDER OF.... (UNITED STATES), followed by TO THE ORDER OF (UNITED STATES) and CAMBER PHARMACEUTICALS INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Posaconazole Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
POSACONAZOLE TABLET	$333.7K	9
POSACONAZOLE TABLET 60SNOS	$150.0K	3
POSACONAZOLE TABLET 60S	$150.0K	3
POSACONAZOLE 100MG TABLET	$100.0K	2
POSACONAZOLE 100MG TABLET 60S	$100.0K	2
POSACONAZOLE 100 MG TABS (QTY IN PACKS 3	$50.0K	1
POSACONAZOLE 100MG TABS (1584 X 60'S PAC	$50.0K	1
POSACONAZOLE 100MG TABS 2202 X 60'S PACK	$50.0K	1
POSACONAZOLE 100MG TABS 2280 X 60'S PACK	$50.0K	1
POSACONAZOLE TABS	$50.0K	1

Hetero Labs Limited exports 16 distinct Posaconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is POSACONAZOLE TABLET with 9 shipments worth $333.7K.

How Does Hetero Labs Limited Compare to Nearest Posaconazole Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	AET LABORATORIES PRIVATE LIMITED	$6.0M	121	9	$50.0K
2	HETERO LABS LIMITED ★	$1.5M	30	6	$50.0K
4	MSN LABORATORIES PRIVATE LIMITED	$307.2K	8	3	$38.4K
3	GLAND PHARMA LTD	$300.0K	6	1	$50.0K

Hetero Labs Limited ranks #2 among 51 Indian Posaconazole exporters. Average shipment value of $50.0K compared to the market average of $161.9K. The closest competitors by value are AET LABORATORIES PRIVATE LIMITED and MSN LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Posaconazole Exports?

Port	Shipments	% Share
HYDERABAD AIR	56	20.4%
SAHAR AIR	33	12.0%
SAHAR AIR CARGO ACC (INBOM4)	27	9.9%
HYDERABAD ACC (INHYD4)	26	9.5%
DELHI AIR CARGO ACC (INDEL4)	13	4.7%
DELHI AIR	12	4.4%
BANGALORE AIR	11	4.0%
NHAVA SHEVA SEA (INNSA1)	10	3.6%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Posaconazole Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Posaconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 30 individual customs records matching Hetero Labs Limited exporting Posaconazole, covering 16 formulations to 6 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 41+ countries, 105+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Posaconazole

Posaconazole

Hetero Labs Limited — Posaconazole Exporter Profile

Hetero Labs Limited — Posaconazole Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Posaconazole?

Who Are the Top Buyers of Posaconazole from Hetero Labs Limited?

What Is India's Total Posaconazole Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Posaconazole Exports?

How Does Hetero Labs Limited Compare to Other Indian Posaconazole Exporters?

What Posaconazole Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Posaconazole to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Hetero Labs Limited Compare to Nearest Posaconazole Exporters?

Which Indian Ports Ship Posaconazole Exports?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Posaconazole Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Posaconazole Export Data from Hetero Labs Limited

Posaconazole Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source